News

The 4^th round of IPH Conference and Exhibition was held here in Theran, IRIB International Conference Center on 3-5 September 2025 through which the hospitals and healthcare centers involved with international patients made their presence by holding up their stands.

Royan Stem Cell Technology Company, enjoying its international mission and vision, held its stand through this event, representing and sharing its services and achievements with its counterparts. There were also sone gatherings along this event where some critical issues, concerned with healthcare problems and barriers, were debated by the experts and researchers so that practical solutions would be spotted.

No wonder, holding up such events will provide an appropriate ground for all the experts, hospital and healthcare managers, authorities and decision-makers to bring up the common issues of such centers and come to a consensus over a solution provided under the umbrella of mutual understanding.

The 26^th Congress on Reproductive Biomedicine and 21^st Congress on Stem Cell Biology and Technology were held by Royan Institute on 3-5 September 2025 and Royan Stem Cell Technology Company (RSCT) made its presence in this scientific event holding up its booth. Considering the main core of this round of Royan International Twin Congress and the essence of RSCT, it could grab the attention of many scholars and students involved and interested in this field of science.

The anniversary of the establishment of this research institute is a valuable opportunity to review scientific achievements, evaluate progress, and honor the efforts of prominent researchers who, with their leadership and knowledge, have paved the way for the development and advancement of this center.

The 5th National Seminar on Alternatives to Laboratory Animals Technologies, in collaboration with Royan Cord Blood Bank, the Research and Technology Deputy of Academic Jihad, the Ministerial Ethics in Research Working Group of the Ministry of Health, Treatment, and Medical Education, Royan Institute, and the Ethics in Research Working Group of Academic Jihad and its University of Science and Culture, will be held on June 18th and 19th in person with retraining points at the International Conference Hall of the University of Science and Culture.

In this note, while examining Iran's population statistics, we will look at the social and health consequences of the declining birth rate, the increase in single-child and childless families, and finally, the role that Royan Cord Blood Bank can play in the future health of the country.

According to the public relations and international affairs of Royan  Institute, abstract submissions for 26th International Royan Twin Congress has been extended to June 5, 2025.
Executive Secretary of the International Royan Congress, stated:
"In response to numerous requests from the scientific community and to ensure inclusive participation, the abstract submission period has been extended. This congress serves as a premier platform for disseminating groundbreaking research in advanced Reproductive Technologies, Stem Cell Sciences, Biotech, and Regenerative Biomedicine."
He further emphasized: "Recognized as one of the region’s most authoritative scientific gatherings, the Royan Congress not only showcases pioneering research but also catalyzes international collaborations among scientists and institutions."
Congress Highlights
This year’s congress will convene distinguished researchers and academic leaders in biomedical biotechnology, offering:

A forum for cutting-edge research presentations
Opportunities for global scientific networking
Discussions on translational applications of emerging technologies

Key Dates & Submission Guidelines
Final Abstract Submission Deadline: June 5, 2025
Submission Portal: www.royancongress.com

Contact:
Secretariat: +98 21 23562455 | +98 21 23563373
Email: info@royancongress.com

Final Deadline for Submitting Research Works to the Royan International Research AwardRoyan International Research Award, a globally renowned event with a distinguished position in the scientific community, once again calls upon leading biomedical researchers to take part in an intellectually stimulating and prestigious scientific competition. Organized by the Royan Institute, this festival aims to expand the frontiers of knowledge, honor scientific endeavors, and strengthen international collaborations. Today, it has become a prominent platform for showcasing and supporting exceptional scientific talent.
As we approach the 24th Royan International Research Award, we invite researchers and scholars to submit their valuable scientific papers through the website: www.royanaward.com.
Please note that the submission deadline is set for May 10, 2025. The closing ceremony will take place simultaneously with the Royan International Congress in September 2025 in Tehran. Only works completed within the last three years and published in high-impact scientific journals will be eligible for review. Submissions will be evaluated by a panel of distinguished national and international experts, and the final awardees will be honored in a grand ceremony.
Selected researchers will receive not only a prestigious honor statuette, a certificate of recognition, and a $5,000 cash prize but also a rare opportunity to present their scientific findings at the Royan Twin International Congress—a platform designed for visibility, international scientific interaction, and the expansion of new horizons in science.
If you are looking for an opportunity to make a global impact in the world of research, the Royan Award, the largest biomedical Award in the Middle East, is truly the gateway to a bright and scientifically promising future.

On April 20, 2025, the Dean of the Faculty of Pharmacy of Bu Ali Sina University in Dushanbe, Tajikistan, Dr. Ramzan Safarzadeh, visited the Embryonic Stem Cell Technology Company (RSCT), which was followed by a meeting with the CEO of the Embryonic Stem Cell Technology Company.

During this meeting, the parties discussed areas of mutual interest, while recounting and referring to the cultural-historical commonalities between the two countries, the history of economic and scientific interactions, as well as the potentials existing in both countries.

In the continuation of this meeting, Dr. Zarrabi, CEO of the Embryonic Stem Cell Technology Company, referred to the capabilities available in the company and the recent advances that have been made in the field of using umbilical cord blood stem cells to treat many incurable diseases and products derived from the obstetric appendages, some of which have been possible to extract with the help of the company's scientists and researchers, and announced the readiness of the Embryonic Stem Cell Technology Company for scientific interaction with the Bu Ali Sina University in Dushanbe, Tajikistan, and the Ministry of Health of Tajikistan.

 

Dr. Safarzadeh also stated that significant steps have been taken in the field of stem cell application by the Embryonic Stem Cell Technology Company, and announced the interest and readiness of Bu Ali Sina University and the Tajik Health Network to establish scientific cooperation, and called for the transfer of this field of science and knowledge to Tajikistan.